These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27260462)

  • 21. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic literature review of the effect of anthocyanins on gut microbiota populations.
    Igwe EO; Charlton KE; Probst YC; Kent K; Netzel ME
    J Hum Nutr Diet; 2019 Feb; 32(1):53-62. PubMed ID: 29984532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.
    Horta-Baas G; Romero-Figueroa MDS; Montiel-Jarquín AJ; Pizano-Zárate ML; García-Mena J; Ramírez-Durán N
    J Immunol Res; 2017; 2017():4835189. PubMed ID: 28948174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of fruits based on anthocyanin types and relevance to their health effects.
    Fang J
    Nutrition; 2015; 31(11-12):1301-6. PubMed ID: 26250485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective Effects of Anthocyanins in Obesity-Associated Inflammation and Changes in Gut Microbiome.
    Jayarathne S; Stull AJ; Park OH; Kim JH; Thompson L; Moustaid-Moussa N
    Mol Nutr Food Res; 2019 Oct; 63(20):e1900149. PubMed ID: 31389663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide.
    Zhang J; Yang G; Wen Y; Liu S; Li C; Yang R; Li W
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28679026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of modulation of gut microbiota by dietary polyphenols.
    Dueñas M; Muñoz-González I; Cueva C; Jiménez-Girón A; Sánchez-Patán F; Santos-Buelga C; Moreno-Arribas MV; Bartolomé B
    Biomed Res Int; 2015; 2015():850902. PubMed ID: 25793210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyphenols as modulators of pre-established gut microbiota dysbiosis: State-of-the-art.
    Molinari R; Merendino N; Costantini L
    Biofactors; 2022 Mar; 48(2):255-273. PubMed ID: 34397132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation effect of tea consumption on gut microbiota.
    Liu YC; Li XY; Shen L
    Appl Microbiol Biotechnol; 2020 Feb; 104(3):981-987. PubMed ID: 31853562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.
    Duda-Chodak A; Tarko T; Satora P; Sroka P
    Eur J Nutr; 2015 Apr; 54(3):325-41. PubMed ID: 25672526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of gut microbiota with functional food components and nutraceuticals.
    Laparra JM; Sanz Y
    Pharmacol Res; 2010 Mar; 61(3):219-25. PubMed ID: 19914380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders.
    Thumann TA; Pferschy-Wenzig EM; Moissl-Eichinger C; Bauer R
    J Ethnopharmacol; 2019 Dec; 245():112153. PubMed ID: 31408679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts.
    Anhê FF; Varin TV; Le Barz M; Desjardins Y; Levy E; Roy D; Marette A
    Curr Obes Rep; 2015 Dec; 4(4):389-400. PubMed ID: 26343880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microbiota in adaptive immune homeostasis and disease.
    Honda K; Littman DR
    Nature; 2016 Jul; 535(7610):75-84. PubMed ID: 27383982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low anthocyanin plum nectar does not impact cognition, blood pressure and gut microbiota in healthy older adults: A randomized crossover trial.
    Igwe EO; Roodenrys S; Probst YC; do Rosario V; Netzel ME; Hong HT; Netzel G; Phan ADT; Charlton KE
    Nutr Res; 2020 Oct; 82():74-87. PubMed ID: 32977254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.